The insulin-like growth factor system in vascular smooth muscle: interaction with insulin and growth factors
- PMID: 7476313
- DOI: 10.1016/0026-0495(95)90222-8
The insulin-like growth factor system in vascular smooth muscle: interaction with insulin and growth factors
Abstract
Vascular smooth muscle cells (SMCs) occur throughout the vascular tree and have important physiological functions. They are also involved in pathological processes such as development and progression of atherosclerotic lesions, restenosis following angioplasty, and in hypertension. This review is focused on the role of the insulin-like growth factor (IGF) system in proliferation, migration, and hypertrophy of vascular SMCs and its interaction with insulin and other growth factors. The IGF-I receptor is highly expressed in SMCs in intact arteries and in cultured SMCs and is activated by binding of IGF-I to the two alpha-subunits. Insulin and IGF-II from the circulation can interact with the IGF-I receptor at higher concentrations. Insulin receptors are few or absent in SMCs and circulating insulin concentrations in vivo are probably too low for a direct action of insulin on the IGF-I receptor in SMCs. Receptor activation initiates a number of signal transduction pathways. Increased phosphatidylinositol turnover and calcium mobilization correlates with actin filament reorganization and stimulation of directed migration of the SMC in a gradient of IGF-I. The effects of IGF-I receptor activation on signal transduction pathways (eg, the MAP kinase cascade) implicated in DNA synthesis and proliferation are weak and this correlates with the meager mitogenic activity of IGF-I in SMC. Several components of the IGF-system in SMC are regulated by growth factors such as platelet-derived growth factor (PDGF)-BB and basic fibroblast growth factor (bFGF).(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation.J Clin Invest. 1994 Mar;93(3):1266-74. doi: 10.1172/JCI117081. J Clin Invest. 1994. PMID: 8132765 Free PMC article.
-
Insulin, insulin-like growth factor I and platelet-derived growth factor interact additively in the induction of the protooncogene c-myc and cellular proliferation in cultured bovine aortic smooth muscle cells.Mol Endocrinol. 1989 Aug;3(8):1183-90. doi: 10.1210/mend-3-8-1183. Mol Endocrinol. 1989. PMID: 2674692
-
On how insulin may influence ageing and become atherogenic throughout the insulin-like growth factor-1 receptor pathway: in vitro studies with human vascular smooth muscle cells.Gerontology. 2005 Jul-Aug;51(4):225-30. doi: 10.1159/000085118. Gerontology. 2005. PMID: 15980650
-
Signal transduction in arteriosclerosis: mechanical stress-activated MAP kinases in vascular smooth muscle cells (review).Int J Mol Med. 1998 May;1(5):827-34. doi: 10.3892/ijmm.1.5.827. Int J Mol Med. 1998. PMID: 9852303 Review.
-
Platelet-derived growth factor. Distinct signal transduction pathways associated with migration versus proliferation.Ann N Y Acad Sci. 1995 Sep 7;766:416-30. doi: 10.1111/j.1749-6632.1995.tb26691.x. Ann N Y Acad Sci. 1995. PMID: 7486687 Review.
Cited by
-
DrugShot: querying biomedical search terms to retrieve prioritized lists of small molecules.BMC Bioinformatics. 2022 Feb 19;23(1):76. doi: 10.1186/s12859-022-04590-5. BMC Bioinformatics. 2022. PMID: 35183110 Free PMC article.
-
SM22α (Smooth Muscle Protein 22-α) Promoter-Driven IGF1R (Insulin-Like Growth Factor 1 Receptor) Deficiency Promotes Atherosclerosis.Arterioscler Thromb Vasc Biol. 2018 Oct;38(10):2306-2317. doi: 10.1161/ATVBAHA.118.311134. Arterioscler Thromb Vasc Biol. 2018. PMID: 30354209 Free PMC article.
-
A selective somatostatin type-2 receptor agonist inhibits neointimal thickening and enhances endothelial cell growth and morphology following aortic balloon injury in the rabbit.Mol Cell Biochem. 2002 Nov;240(1-2):31-7. doi: 10.1023/a:1020679809056. Mol Cell Biochem. 2002. PMID: 12487369
-
Dysregulation of the Mammalian Target of Rapamycin and p27Kip1 Promotes Intimal Hyperplasia in Diabetes Mellitus.Pharmaceuticals (Basel). 2013 May 27;6(6):716-27. doi: 10.3390/ph6060716. Pharmaceuticals (Basel). 2013. PMID: 24276258 Free PMC article.
-
IGF-I stimulates cooperative interaction between the IGF-I receptor and CSK homologous kinase that regulates SHPS-1 phosphorylation in vascular smooth muscle cells.Mol Endocrinol. 2011 Sep;25(9):1636-49. doi: 10.1210/me.2011-0035. Epub 2011 Jul 28. Mol Endocrinol. 2011. PMID: 21799000 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical